Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 10/20 | 0.35 |
| ▸ | ACACB | O00763 | 5/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12821191 | 0.90 | GPR119 (0.34) | GPR119MAOAMAOBFFAR1ACACB | |
| SCHEMBL12822800 | 0.90 | GPR119 (0.35) | GPR119MAOAMAOBFFAR1ACACB | |
| SCHEMBL14766390 | 0.89 | HTR1A (0.34) | GPR119MAOAMAOB | |
| SCHEMBL12821333 | 0.88 | GPR119 (0.33) | GPR119MAOAMAOBFFAR1ACACB | |
| SCHEMBL12736672 | 0.88 | GPR119 (0.35) | GPR119MAOAMAOBFFAR1FFAR4 | |
| SCHEMBL10303248 | 0.88 | MAOA (0.38) | GPR119MAOAMAOBFFAR1ACACB | |
| SCHEMBL10302634 | 0.88 | GPR119 (0.36) | GPR119MAOAMAOBFFAR1FFAR4 | |
| SCHEMBL13586397 | 0.87 | HCRTR2 (0.35) | GPR119MAOAMAOBFFAR1ACACB | |
| SCHEMBL12823458 | 0.87 | ACACB (0.35) | GPR119MAOAMAOBACACB | |
| SCHEMBL12736673 | 0.87 | GPR119 (0.33) | GPR119MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009150966-A1 | TETRACYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | チッソ株式会社 (JP) | 2009-12-17 | — | — | WO | disclosed |